Rinvoq Receives FDA Approval for Moderate to Severe Crohn's Disease
AbbVie’s JAK inhibitor Rinvoq (upadacitinib) is now the only oral medication approved to treat moderate to severe Crohn’s disease.
Source: everydayhealth.com
Stay updated with breaking news from That Can Work Quickly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie’s JAK inhibitor Rinvoq (upadacitinib) is now the only oral medication approved to treat moderate to severe Crohn’s disease.